Renal Transplantation Outcomes and Treatments
Renal Transplantation Outcomes and Treatments is a research topic within Transplantation. Science Explorer counts 46k research works in it since 1951. 16.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on advancements in kidney transplantation research, including topics such as renal allograft pathology, immunosuppressive drugs, antibody-mediated rejection, graft survival, chronic allograft nephropathy, HLA antibodies, tacrolimus pharmacogenetics, delayed graft function, and the impact of donor-specific antibodies. The papers cover a wide range of issues related to kidney transplantation and aim to improve outcomes for transplant recipients.
- Kidney Transplantation
- Renal Allograft
- Immunosuppressive Drugs
- Antibody-Mediated Rejection
- Graft Survival
- Chronic Allograft Nephropathy
- HLA Antibodies
- Tacrolimus Pharmacogenetics
- Delayed Graft Function
- Donor-Specific Antibodies
- Research works
- 46k fractional, since 1951
- In the world top 10%
- 7.3k per year above
- Top-10% rate
- 16.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +22% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Renal Transplantation Outcomes and Treatments research?
By volume, the United States and China publish the most (2.8k and 558 works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.8k works
- 2 China 558 works
- 3 India 294 works
- 4 United Kingdom 288 works
- 5 South Korea 275 works
- 6 Japan 275 works
- 7 Canada 271 works
- 8 France 270 works
- 9 Spain 255 works
- 10 Germany 254 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Renal Transplantation Outcomes and Treatments research?
By volume in 2022–2025, Stanford University publishes the most Renal Transplantation Outcomes and Treatments research, followed by Cleveland Clinic and University of Pennsylvania.
By volume, 2022–2025
- 1 Stanford UniversityUnited States 39 works
- 2 Cleveland ClinicUnited States 39 works
- 3 University of PennsylvaniaUnited States 37 works
- 4 Johns Hopkins UniversityUnited States 36 works
- 5 Emory UniversityUnited States 34 works
- 6 Northwestern UniversityUnited States 34 works
- 7 University of Wisconsin–MadisonUnited States 33 works
- 8 University of California, San FranciscoUnited States 33 works
- 9 University of ChicagoUnited States 33 works
- 10 Washington University in St. LouisUnited States 32 works
Who are the leading researchers in Renal Transplantation Outcomes and Treatments?
The most-cited researchers publishing on Renal Transplantation Outcomes and Treatments include Giuseppe Remuzzi, Norberto Perico and Marcello Tonelli.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Norberto Perico Italy 6.1k citations
- 3 Marcello Tonelli Canada 5.9k citations
- 4 Alberto Ortíz Spain 5.9k citations
- 5 Vivekanand Jha India 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Renal Transplantation Outcomes and Treatments research done?
The largest centres of Renal Transplantation Outcomes and Treatments research in 2022–2025 are Seoul (South Korea), New York (United States), Los Angeles (United States) and Philadelphia (United States).
Largest cities, 2022–2025
- 1 Seoul South Korea 163 works
- 2 New York United States 156 works
- 3 Los Angeles United States 121 works
- 4 Philadelphia United States 110 works
- 5 Paris France 105 works
- 6 Boston United States 96 works
- 7 Baltimore United States 93 works
- 8 Toronto Canada 84 works
- 9 London United Kingdom 83 works
- 10 Chicago United States 81 works
Where is the best place to study Renal Transplantation Outcomes and Treatments?
Among universities, judged by research, Medical University of Vienna, University of Colorado Anschutz Medical Campus and University of Groningen score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of ViennaAustria | 70.9 | 28.1% | 10.4× | 23 | +8.6% |
| 2 | University of Colorado Anschutz Medical CampusUnited States | 65.9 | 25.5% | 9.8× | 19 | +102.5% |
| 3 | University of GroningenNetherlands | 62.4 | 40.6% | 3.6× | 13 | +104.7% |
| 4 | University of California, San FranciscoUnited States | 58.4 | 17.3% | 7.3× | 33 | +38.7% |
| 5 | Duke UniversityUnited States | 57.7 | 23.6% | 4.8× | 24 | +135.8% |
| 6 | KU LeuvenBelgium | 56.8 | 32.6% | 3.3× | 21 | +16.5% |
| 7 | Medizinische Hochschule HannoverGermany | 56.7 | 15.1% | 15.2× | 23 | -7.0% |
| 8 | Virginia Commonwealth UniversityUnited States | 56.2 | 17.2% | 9.5× | 22 | +17.7% |
| 9 | Stanford UniversityUnited States | 53.5 | 18.3% | 4.5× | 39 | +26.1% |
| 10 | Indiana University School of Medicine?? | 53.4 | 22.1% | 9.8× | 11 | +39.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Renal Transplantation Outcomes and Treatments research growing?
Output in 2018–2022 was 22% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Renal Transplantation Outcomes and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.